SCHEMBL5316765

SCHEMBL5316765

COC(=O)/C=C/c1nn(Cc2ccc(Cl)cc2Cl)c2cc(N)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
PMP22 Q01453 1/20 0.44
HIF1A Q16665 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ALDH1A1 P00352 2/20 0.41
PPARG P37231 4/20 0.41
TP53 P04637 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
JAK2 O60674 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
ENPP2 Q13822 1/20 0.40
NPC1 O15118 1/20 0.39
SLC16A3 O15427 2/20 0.39
SLC16A1 P53985 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316766 1.00 LMNA (0.44) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1047152 0.93 CYP1A2 (0.47) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1047153 0.93 CYP1A2 (0.47) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5319335 0.91 ENPP2 (0.40) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5319334 0.91 ENPP2 (0.40) LMNACYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5321079 0.91 TP53 (0.42) LMNATP53SMN1; SMN2ENPP2MAPT
SCHEMBL5321075 0.91 TP53 (0.42) LMNATP53SMN1; SMN2ENPP2MAPT
SCHEMBL5318381 0.91 ENPP2 (0.43) LMNAPPARGENPP2
SCHEMBL5318383 0.91 ENPP2 (0.43) LMNAPPARGENPP2
SCHEMBL12787864 0.89 LMNA (0.47) LMNACYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed